As part of the Cambridge Science Festival, the Cambridge Drug Discovery Institute is opening its doors to the public.
PhoreMost Ltd, a UK biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a research collaboration with the laboratory of Prof David Rubinsztein at the University of Cambridge. Prof Rubinsztein’s lab focuses on understanding how autophagy, a cellular waste disposal system, could be manipulated to clear toxic protein build-up occurring in neurodegenerative diseases […]
It has been over a hundred years since Alzheimer’s disease was first described, and in that time we have learned much about the condition, but how close are we to having effective treatments and could one day we prevent dementia from even occurring? Released on World Alzheimer’s Day, September 21, a short film by the […]
Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30m Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments […]